Denali Therapeutics (DNLI) ROA US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ?
ROA, % ? -20.7% -22.3% -12.6% -30.8% -44.8%   -40.1%
Changes by years, y/y, % -25pp -2pp +10pp -18pp -14pp    

Denali Therapeutics. ROA, %

Denali Therapeutics. ROA, changes, pp

Denali Therapeutics (DNLI) ROA US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
ROA, % ? -35.7% -41.1% -47.2% -44.8% -40.1%   -40.1%
Changes by years, y/y, % -27pp -13pp -18pp -14pp -4pp    
Changes by quarters, q/q, % -5pp -5pp -6pp +2pp +5pp    

Denali Therapeutics. ROA, %

Denali Therapeutics. ROA, changes, pp

Denali Therapeutics. ROA, changes, pp